BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9665084)

  • 1. Thrombotic microangiopathy in association with cytomegalovirus infection in a renal transplant patient: a new treatment strategy.
    Jeejeebhoy FM; Zaltzman JS
    Transplantation; 1998 Jun; 65(12):1645-8. PubMed ID: 9665084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus-induced thrombotic microangiopathy after renal transplant successfully treated with eculizumab: case report and review of the literature.
    Java A; Edwards A; Rossi A; Pandey R; Gaut J; Delos Santos R; Miller B; Klein C; Brennan D
    Transpl Int; 2015 Sep; 28(9):1121-5. PubMed ID: 25864519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic microangiopathy and cytomegalovirus in liver transplant recipients: a case-based review.
    Ramasubbu K; Mullick T; Koo A; Hussein M; Henderson JM; Mullen KD; Avery RK
    Transpl Infect Dis; 2003 Jun; 5(2):98-103. PubMed ID: 12974791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-emptive therapy of CMVpp65 antigen positive renal transplant recipients with oral ganciclovir: a randomized, comparative study.
    Sagedal S; Nordal KP; Hartmann A; Midtvedt K; Foss A; Asberg A; Degré M; Fauchald P; Rollag H
    Nephrol Dial Transplant; 2003 Sep; 18(9):1899-908. PubMed ID: 12937241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus disease with atypical presentation in a renal transplant patient: case report.
    Khosravi M; Nobakht A; Nikokar AR
    Exp Clin Transplant; 2006 Jun; 4(1):458-61. PubMed ID: 16827643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo thrombotic microangiopathy induced by cytomegalovirus infection leading to renal allograft loss.
    De Keyzer K; Van Laecke S; Peeters P; Vanholder R
    Am J Nephrol; 2010; 32(5):491-6. PubMed ID: 20975262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment with foscarnet for ganciclovir-resistant cytomegalovirus infection in a kidney transplant recipient: A case report.
    Iwami D; Ogawa Y; Fujita H; Morita K; Sasaki H; Oishi Y; Higuchi H; Hatanaka K; Shinohara N
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():63-6. PubMed ID: 26970406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Panresistant cytomegalovirus in a kidney transplant recipient.
    Yost SE; Echeverria A; Jie T; Kaplan B
    Pharmacotherapy; 2014 Jan; 34(1):e1-3. PubMed ID: 24277702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent Primary Cytomegalovirus Infection After Deceased Donor Kidney Transplant: Ganciclovir Susceptibility of Human Cytomegalovirus With UL97 D605E Mutation: A Case Report.
    Nawashiro Y; Shiraki K; Yamamoto S; Takizawa K; Sasada Y; Suehiro M; Miura K; Hattori M; Daikoku T; Hisano M
    Transplant Proc; 2018 Dec; 50(10):3932-3936. PubMed ID: 30577289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral escape and T-cell immunity during ganciclovir treatment of cytomegalovirus infection: case report of a pancreatico-renal transplant recipient.
    Benz C; Holz G; Michel D; Awerkiew S; Dries V; Stippel D; Goeser T; Busch DH
    Transplantation; 2003 Mar; 75(5):724-7. PubMed ID: 12640316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case Report of a Rare Presentation of Isolated Cytomegalovirus Hepatitis After Renal Transplantation.
    Soape MP; Rahimi RS; Spak CW; Trotter JF
    Prog Transplant; 2018 Sep; 28(3):296-298. PubMed ID: 29898621
    [No Abstract]   [Full Text] [Related]  

  • 12. Case of anti-glomerular basement membrane antibody-induced glomerulonephritis with cytomegalovirus-induced thrombotic microangiopathy.
    Shiraishi N; Kitamura K; Hayata M; Ogata T; Adachi M; Kajiwara K; Ikeda H; Miyoshi T; Tomita K
    Intern Med J; 2012 Mar; 42(3):e7-e11. PubMed ID: 22432999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of cytomegalovirus infection after renal transplantation: experience from a single center in China.
    Li Y; Yan H; Xue WJ; Tian PX; Ding XM; Pan XM; Feng XS; Xiang HL; Hou J; Tian XH; Zheng J; Ding CG; Fan P; Liu HB
    Ann Transplant; 2013 Mar; 18():125-35. PubMed ID: 23792512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similar reduction of cytomegalovirus DNA load by oral valganciclovir and intravenous ganciclovir on pre-emptive therapy after renal and renal-pancreas transplantation.
    Kalpoe JS; Schippers EF; Eling Y; Sijpkens YW; de Fijter JW; Kroes AC
    Antivir Ther; 2005; 10(1):119-23. PubMed ID: 15751769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial cytomegalovirus prophylaxis with ganciclovir: no guarantee for prevention of late serious manifestations of CMV after solid organ transplantation.
    Zandberg M; de Maar EF; Hofker HS; Homan van der Heide JJ; Rosati S; van Son WJ
    Neth J Med; 2005 Nov; 63(10):408-12. PubMed ID: 16301763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case report of CMV hepatitis and nephropathy after living related renal transplantation].
    Tanaka S; Fujioka M; Sasaki S
    Nihon Geka Gakkai Zasshi; 1993 Dec; 94(12):1305-8. PubMed ID: 8272070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CARI guidelines. CMV disease and kidney transplant: treatment of cytomegalovirus disease in renal transplant recipients.
    Caring for Australians with Renal Impairment (CARI)
    Nephrology (Carlton); 2004 Oct; 9 Suppl 3():S37-40. PubMed ID: 15469554
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined foscarnet-ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation.
    Bacigalupo A; Bregante S; Tedone E; Isaza A; Van Lint MT; Trespi G; Occhini D; Gualandi F; Lamparelli T; Marmont AM
    Transplantation; 1996 Aug; 62(3):376-80. PubMed ID: 8779686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of oral acyclovir or ganciclovir therapy after preemptive intravenous ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus seropositive renal and liver transplant recipients receiving antilymphocyte antibody therapy.
    Turgeon N; Fishman JA; Basgoz N; Tolkoff-Rubin NE; Doran M; Cosimi AB; Rubin RH
    Transplantation; 1998 Dec; 66(12):1780-6. PubMed ID: 9884276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing cytomegalovirus prophylaxis in renal transplantation: single center experience.
    Varga M; Remport A; Hídvégi M; Péter A; Kóbori L; Telkes G; Fazakas J; Gerlei Z; Sárváry E; Sulyok B; Járay J
    Transpl Infect Dis; 2005 Jun; 7(2):63-7. PubMed ID: 16150092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.